Weight loss and diabetes drugs

Gobles man charged for selling mislabeled, unprescribed GLP1s | WKZO | Everything Kalamazoo | 590 AM · 106.9 FM

Fake 'Ozempic-like' drugs flooding Canada pose a serious danger, feds report | INsauga

Police launch probe into fake weight-loss medication being sold in Wales | Wales Online

Investigation launched into sale of illegal weight-loss medication in Wrexham and Flintshire - Wrexham.com

Boothwyn Pharmacy, LLC - 717525 - 01/16/2026 | FDA

Health agency refers knockoff GLP-1 provider Hims & Hers to Justice Department - WSJ

Hims & Hers launches copy of Wegovy pill, prompting legal threats | MedPage Today

Hims shares plunge after FDA chief threatens action on 'illegal copycat drugs'

Short Takes and Updates February 6, 2026 | FDA Matters

MHRA updates guidance for semaglutide prescribers and patients - GOV.UK

Phoenix MD suspension letter

Exclusive -- Coalition Urges FDA to Stop Sale of Counterfeit Weight Loss Drugs

The nightmare Mounjaro side effect which led me turning to the 'grey web' - it's not safe but I'm desperate to be thin

Fake weight-loss medication in tablet form could flood Britain, experts warn | Weight-loss drugs | The Guardian

Health Canada warns about fake or unauthorized versions of GLP-1 drugs | CBC News

Former Chicago nurse charged with giving out counterfeit Ozempic – NBC Chicago

Revealed: the crypto entrepreneur linked to illegal weight-loss drug operation | Weight-loss drugs | The Guardian

Pharmacist warns of 'significant risk' for Mounjaro and Wegovy orders | Western Telegraph

The next Ozempic is already being sold underground - The Atlantic

MHRA urges public to avoid illegal online weight-loss medicines this New Year - GOV.UK

People Are Injecting Themselves With an Experimental New Weight Loss Drug

Company linked to raid on illicit weight-loss drug facility still selling unlicensed drugs | Consumer affairs | The Guardian

National Advertising Division refers Willow Health to regulatory authorities - BBB National Programs

FTC approves final order against telehealth provider Nextmed over charges it used deceptive advertising claims to sell GLP-1 weight-loss programs | Federal Trade Commission

Doctors warn against counterfeit GLP-1 weight-loss drugs after SAHPRA alert

Amylin could reign supreme in the next wave of obesity drugs | PharmaVoice

The next weight-loss drug is here — but it’s fake and untested

Local wellness spa accused of using ‘gray market’ weight loss drugs | The Cullman Times

Lilly to advance alternative obesity candidate to phase III - Clinical Trials Arena

Iowa courts: Pharmacy settles lawsuit over counterfeit Ozempic sales